Antibody Information

General Information of This Antibody
Antibody ID
ANTI0CPZYD
Antibody Name
20D7
Organization
Pfizer Inc.
Synonyms
20D7
   Click to Show/Hide
Antigen Name
Interleukin-3 receptor subunit alpha (IL3RA)
  Antigen Info 
Click to Show/Hide the Sequence Information of This Antibody
Heavy Chain Sequence
EVQLVESGGGLVQPGGSLRLSCAASGYSITDFLMYWVRQAPGKGLEWVAWIDPEDGETKY
AQKFQSKARFTISRDNAKNSLYLQMNSLRAEDTAVYYCARWGYITDYFYGGFTYWGRGTL
VTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPA
VLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDRTHTCPPCPAP
ELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPR
ELLQGSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLP
PSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTV
DKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG
    Click to Show/Hide
Heavy Chain Varible Domain
EVQLQQSGPELRRPGTSVKLSCKASGYSITDFLMYWVKHRPEYGLEWIGWDPEDGETKYA
QKFQSKARLTADTSSKTAYMELSSLTSEDTATYFCARWGYITDYFYGGFTYWGRGTLVTV
SS
    Click to Show/Hide
Heavy Chain CDR 1
GYSITDFLMY
    Click to Show/Hide
Heavy Chain CDR 2
WIDPEDGETKYAQKFOS
    Click to Show/Hide
Heavy Chain CDR 3
WGYITDYFYGGFTY
    Click to Show/Hide
Light Chain Sequence
DIQMTQSPPVLSASVGDRVTLSCKASQNINKNLDWYQQKHGEAPKLLIYHTNTLQMGIPS
RFSGSGSGTDYALTITSLQPEDVATYYCYQYNSGPTFGAGTKLELRRTVAAPSVFIFPPS
DEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTL
SKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC
    Click to Show/Hide
Light Chain Varible Domain
DIQMTQSPPVLSASVGDRVTLSCKASQNINKNLDWYQQKHGEAPKLLIYHTNTLQMGIPS
RFSGSGSGTDYALTITSLQPEDVATYYCYQYNSGPTFGAGTKLELR
    Click to Show/Hide
Light Chain CDR 1
KASQNINKNLD
    Click to Show/Hide
Light Chain CDR 2
HTNTLQM
    Click to Show/Hide
Light Chain CDR 3
YQYNSGPT
    Click to Show/Hide
Each Antibody-drug Conjugate Related to This Antibody
Full Information of The Activity Data of The ADC(s) Related to This Antibody
JP2024177330A5 20D7-CPI [Investigative]
 ADC Info 
Revealed Based on the Cell Line Data
Click To Hide/Show 1 Activity Data Related to This Level
Experiment 1 Reporting the Activity Date of This ADC [1]
Efficacy Data Half Maximal inhibitory Concentration (lC50)
0.32 ng/mL
High CD123 expression (CD123+++)
Method Description
MOLM13 cell line cells were incubated with ADC or control at the following doses: 100 ng/ml, 25 ng/ml, 6.25 ng/ml, 1.56 ng/ml, 0.39 ng/ml, 0.09 ng/ml, 0.024 ng/ml, 0.006 ng/ml, 0.002 ng/ml and 0.0004 ng/ml. for 96 hours. Cell viability was measured with CelltiterGlo (Promega, Madison, WI), and luminescence was determined using a Victor plate reader (Perkin Elmer, Waltham, MA). 50% inhibition value (IC50) calculations were generated using XLfit (IDBS, Boston, MA) 4 parameter curve fit.

   Click to Show/Hide
In Vitro Model Adult acute myeloid leukemia MOLM-13 cells CVCL_2119
References
Ref 1 JP2024177330A5 - Google Patents